Product Information
OXCARBAZEPINE 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1664 per EA under NDC 31722002401. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722002401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215939On Market Since
1/11/2022
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1664 per EA |
|---|---|
| All-time high | $0.2198 (Aug 10, 2022) |
| All-time low | $0.1454 (Nov 20, 2024) |
| 52-week high | $0.1757 |
| 52-week low | $0.1664 |
| Median price | $0.1898 |
| Average price | $0.1878 |
| Largest weekly change | +25.1% (Aug 21, 2024) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1664 per EA (NDC 31722002401), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 24.3%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Aug 10, 2022, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1454 (Nov 20, 2024) to a high of $0.2198 (Aug 10, 2022), with a median of $0.1898 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as OXCARBAZEPINE 300 MG TABLET, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 31722002401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification